-+ 0.00%
-+ 0.00%
-+ 0.00%

Bristol-Myers Squibb's third-quarter results exceeded expectations, raising revenue expectations for 2026, and the pre-market stock price rose 2.2%.

Zhitongcaijing·10/29/2026 11:09:29
Listen to the news
Bristol-Myers Squibb's third-quarter results exceeded expectations, raising revenue expectations for 2026, and the pre-market stock price rose 2.2%.